Measles immunity after allogeneic stem cell transplantation; influence of donor type, graft type, intensity of conditioning, and graft-versus host disease

This publication has 14 references indexed in Scilit:

• Transplantation of Peripheral Blood Stem Cells as Compared With Bone Marrow From HLA-Identical Siblings in Adult Patients With Acute Myeloid Leukemia and Acute Lymphoblastic Leukemia
  Journal of Clinical Oncology, 2002
• Risk factors for moderate-to-severe chronic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation.
  Transplantation and Cellular Therapy, 2002
• Measles in bone marrow transplant recipients during an outbreak in São Paulo, Brazil
  Blood, 2002
• Peripheral Blood Stem Cell Transplantation From Unrelated Donors: A Comparison With Marrow Transplantation
  Blood, 1999
• Immunization of transplant recipients
  Bone Marrow Transplantation, 1999
• LOW INCIDENCE OF ACUTE GRAFT-VERSUS-HOST DISEASE, USING UNRELATED HLA-A-, HLA-B-, AND HLA-DR-COMPATIBLE DONORS AND CONDITIONING, INCLUDING ANTI-T-CELL ANTIBODIES1
  Transplantation, 1998
• Clinical features of measles in immunocompromised children
  Pediatrics International, 1996
• Long-term immunity to measles, mumps, and rubella after allogeneic bone marrow transplantation
  Blood, 1994
• Efficacy and Safety of Vaccination of Marrow Transplant Recipients with a Live Attenuated Measles, Mumps, and Rubella Vaccine
  The Journal of Infectious Diseases, 1989
• Fatal measles encephalopathy with retinopathy during cytotoxic chemotherapy
  Journal of the Neurological Sciences, 1977